BLC
PFE icon

Brown, Lisle/Cummings’s Pfizer PFE Stock Holding History

Brown, Lisle/Cummings’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
74,737
+7,752
+12% +$203K 0.4% 64
2026
Q1 		$1.88M Buy
66,985
+148
+0.2% +$3.94K 0.47% 52
2025
Q4 		$1.66M Buy
66,837
+2,301
+4% +$58K 0.41% 59
2025
Q3 		$1.64M Sell
64,536
-5,070
-7% -$125K 0.42% 57
2025
Q2 		$1.69M Buy
69,606
+7,101
+11% +$166K 0.45% 55
2025
Q1 		$1.58M Buy
62,505
+1,197
+2% +$31.3K 0.46% 54
2024
Q4 		$1.63M Buy
61,308
+3,824
+7% +$104K 0.49% 54
2024
Q3 		$1.66M Buy
57,484
+158
+0.3% +$4.61K 0.51% 51
2024
Q2 		$1.6M Buy
57,326
+2,263
+4% +$62.3K 0.52% 48
2024
Q1 		$1.53M Buy
55,063
+4,843
+10% +$134K 0.52% 47
2023
Q4 		$1.45M Buy
50,220
+15,990
+47% +$483K 0.54% 47
2023
Q3 		$1.14M Buy
34,230
+7,927
+30% +$280K 0.51% 49
2023
Q2 		$965K Buy
26,303
+4,879
+23% +$190K 0.43% 57
2023
Q1 		$874K Buy
21,424
+1,457
+7% +$62.9K 0.44% 54
2022
Q4 		$1.02M Buy
19,967
+1,749
+10% +$83.9K 0.55% 48
2022
Q3 		$797K Buy
18,218
+2,730
+18% +$133K 0.47% 53
2022
Q2 		$812K Sell
15,488
-432
-3% -$22K 0.45% 58
2022
Q1 		$824K Sell
15,920
-432
-3% -$22.4K 0.4% 62
2021
Q4 		$966K Buy
+16,352
New +$810K 0.48% 52

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown, Lisle/Cummings's PFE Position: Q2 2026 in Review

Brown, Lisle/Cummings increased its Pfizer (PFE) stake by 12% in Q2 2026, buying an estimated $203K and bringing the position to 74,737 shares worth $1.8M. The position accounts for 0.4% of the portfolio, ranked #64.

Brown, Lisle/Cummings first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.88M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Brown, Lisle/Cummings held 74,737 shares of Pfizer worth $1.8M as of Q2 2026.
  • Brown, Lisle/Cummings bought 7,752 Pfizer shares in Q2 2026, an estimated $203K.
  • Pfizer made up 0.4% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #64 holding.
  • Brown, Lisle/Cummings first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Pfizer position peaked at $1.88M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.